Bayer Cropscience Limited (BAYERCROP)
ISIN: - Industry: Agricultural Inputs Sector: Basic Materials Website
4751.8
-28.85(-0.6%)

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and diagnostic imaging equipment and other contrast agents, including computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRiseTM and digital prediction systems that integrate data from farm equipment, satellites, field sensors, irrigation systems, drones, and other input sources and then analyze that data to allow farmers to make decisions through data science and predictive analytics. The company also exports its products. Bayer CropScience Limited was incorporated in 1958 and is based in Thane, India.

Pricing Updates

TODAY'S HIGH

4824

TODAY'S LOW

4702.6

52 WEEK HIGH

5667.75

52 WEEK LOW

4218.05

Major Holders

% of Shares Held by
All Insider

72.72%

% of Shares Held by
Institutions

13.01%

% of Float Held by
Institutions

47.71%

Number of Institutions
Holding Shares

53

Company Overview

MARKET CAP

21383.28 Cr.

ETERPRISE VALUE

20948.07 Cr.

NO. OF SHARES

4.49 Cr.

BOOK VALUE

640.537

DIV. YIELD

100%

DEBT

83.10 Cr.

GROSS PROFIT

2057.30 Cr.

CASH

620.19 Cr.

REVENUE

5072.69 Cr.

REVENUE/SHARE

1128.708

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments23.10 Cr.-1.10 Cr.-40 Cr.-396 Cr.
Change To Liabilities-9.70 Cr.355.80 Cr.-169.10 Cr.250.30 Cr.
Total cashflows from Investing Activities64.20 Cr.6.70 Cr.-28.90 Cr.-414.70 Cr.
Net Borrowings-26.30 Cr.-37 Cr.-22.80 Cr.-22.80 Cr.
Total Cash from Financing Activities-703.30 Cr.-555.80 Cr.-148.30 Cr.-158.30 Cr.
Other Liabilities96.20 Cr.70.20 Cr.53.30 Cr.-43.10 Cr.
Total Assets0000
Net Income645.30 Cr.493.10 Cr.474.50 Cr.337.10 Cr.
Change in Cash-423.60 Cr.137.60 Cr.488.70 Cr.-140.20 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities215.50 Cr.686.70 Cr.665.90 Cr.432.80 Cr.
Depreciation64.50 Cr.73 Cr.63.70 Cr.41.20 Cr.
Other Cashflows from Investing Activities27 Cr.39 Cr.39 Cr.35.80 Cr.
Dividends Paid-672.80 Cr.-516 Cr.-101.50 Cr.-126.10 Cr.
Change to Inventory-236.40 Cr.-395.60 Cr.164.40 Cr.-288.70 Cr.
Change to Account Receivables-256.30 Cr.-37.80 Cr.-20.50 Cr.171.70 Cr.
Other Cashflows from Financing Activities-4.20 Cr.-2.80 Cr.-24 Cr.-32.20 Cr.
Change to Net Income-88.10 Cr.127.50 Cr.98 Cr.-38.30 Cr.
Capital Expenditures-55.40 Cr.-42 Cr.-41.30 Cr.-60.20 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax846.80 Cr.794.50 Cr.583.10 Cr.480 Cr.
Minority InterestNoneNoneNoneNone
Net Income746.60 Cr.738.50 Cr.662.20 Cr.469.10 Cr.
Selling General Administrative463.10 Cr.572.60 Cr.572.90 Cr.601 Cr.
Gross Profit2070.20 Cr.1799.40 Cr.1682.90 Cr.1497.50 Cr.
Ebit746.60 Cr.738.50 Cr.662.20 Cr.469.10 Cr.
Operating Income746.60 Cr.738.50 Cr.662.20 Cr.469.10 Cr.
Other Operating Expenses796 Cr.414.80 Cr.382.50 Cr.383.60 Cr.
Interest Expense-12.90 Cr.-11 Cr.-12.60 Cr.-9.80 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense201.50 Cr.301.40 Cr.108.60 Cr.142.90 Cr.
Total Revenue4734.40 Cr.4261.30 Cr.3609.40 Cr.3175.40 Cr.
Total Operating Expenses3987.80 Cr.3522.80 Cr.2947.20 Cr.2706.30 Cr.
Cost of Revenue2664.20 Cr.2461.90 Cr.1926.50 Cr.1677.90 Cr.
Total Other Income Expense Net100.20 Cr.56 Cr.-79.10 Cr.10.90 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.645.30 Cr.493.10 Cr.474.50 Cr.337.10 Cr.
Net Income Applicable to Common Shares645.30 Cr.493.10 Cr.474.50 Cr.337.10 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets89.30 Cr.70.20 Cr.54 Cr.42.60 Cr.
Capital Surplus0139.40 Cr.139.40 Cr.139.40 Cr.
Total Liabilities1828.60 Cr.1689 Cr.1263.20 Cr.1309.80 Cr.
Stock Holder Equity2524.30 Cr.2550.30 Cr.2572.50 Cr.2239.40 Cr.
Minority Interest0000
Other Liabilities804.90 Cr.644.60 Cr.526.10 Cr.453.60 Cr.
Total Assets4352.90 Cr.4239.30 Cr.3835.70 Cr.3549.20 Cr.
Common Stock44.90 Cr.44.90 Cr.44.90 Cr.34.30 Cr.
Retained Earnings02360.80 Cr.2383 Cr.2049.90 Cr.
Other Liabilities117.50 Cr.104.30 Cr.110 Cr.121.90 Cr.
Good Will0000
Treasury Stock2479.40 Cr.5.20 Cr.5.20 Cr.15.80 Cr.
Other Assets237.70 Cr.224.40 Cr.327.40 Cr.312.90 Cr.
Cash787.40 Cr.1204.50 Cr.1066.90 Cr.578.20 Cr.
Current Liabilities1659.30 Cr.1570.60 Cr.1139.40 Cr.1187.90 Cr.
Long Term Asset Charges7.30 Cr.17.90 Cr.27 Cr.8.90 Cr.
Short Long Term Debt0000
Other Stockholder Equity2479.40 Cr.5.20 Cr.5.20 Cr.15.80 Cr.
Property Plant Equipment450.40 Cr.400.80 Cr.439.90 Cr.413.90 Cr.
Total Cur. Assets3575.50 Cr.3543.90 Cr.3014.40 Cr.2779.80 Cr.
Long Term Investments0000
Net Tangible Assets2435 Cr.2480.10 Cr.2518.50 Cr.2196.80 Cr.
Short Term Investments38.50 Cr.000
Net Receivables1004.70 Cr.763.80 Cr.740.40 Cr.755.90 Cr.
Long Term Debt0000
Inventory1512 Cr.1325.10 Cr.963.50 Cr.1157 Cr.
Accounts Payable819.80 Cr.830.30 Cr.474.90 Cr.644.20 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account